146 related articles for article (PubMed ID: 20832397)
21. Coffin-Lowry syndrome.
Pereira PM; Schneider A; Pannetier S; Heron D; Hanauer A
Eur J Hum Genet; 2010 Jun; 18(6):627-33. PubMed ID: 19888300
[TBL] [Abstract][Full Text] [Related]
22. p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling.
Sheffler DJ; Kroeze WK; Garcia BG; Deutch AY; Hufeisen SJ; Leahy P; Brüning JC; Roth BL
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4717-22. PubMed ID: 16537434
[TBL] [Abstract][Full Text] [Related]
23. Loss of the Coffin-Lowry syndrome-associated gene RSK2 alters ERK activity, synaptic function and axonal transport in Drosophila motoneurons.
Beck K; Ehmann N; Andlauer TF; Ljaschenko D; Strecker K; Fischer M; Kittel RJ; Raabe T
Dis Model Mech; 2015 Nov; 8(11):1389-400. PubMed ID: 26398944
[TBL] [Abstract][Full Text] [Related]
24. Identification of the first deep intronic mutation in the RPS6KA3 gene in a patient with a severe form of Coffin-Lowry syndrome.
Schneider A; Maas SM; Hennekam RC; Hanauer A
Eur J Med Genet; 2013 Mar; 56(3):150-2. PubMed ID: 23261961
[TBL] [Abstract][Full Text] [Related]
25. The Coffin-Lowry syndrome-associated protein RSK2 and neurosecretion.
Zeniou-Meyer M; Gambino F; Ammar MR; Humeau Y; Vitale N
Cell Mol Neurobiol; 2010 Nov; 30(8):1401-6. PubMed ID: 21061166
[TBL] [Abstract][Full Text] [Related]
26. Concomitant partial exon skipping by a unique missense mutation of RPS6KA3 causes Coffin-Lowry syndrome.
Labonne JD; Chung MJ; Jones JR; Anand P; Wenzel W; Iacoboni D; Layman LC; Kim HG
Gene; 2016 Jan; 575(1):42-7. PubMed ID: 26297997
[TBL] [Abstract][Full Text] [Related]
27. Dopaminergic system dysregulation in the mrsk2_KO mouse, an animal model of the Coffin-Lowry syndrome.
Marques Pereira P; Gruss M; Braun K; Foos N; Pannetier S; Hanauer A
J Neurochem; 2008 Dec; 107(5):1325-34. PubMed ID: 18823370
[TBL] [Abstract][Full Text] [Related]
28. Four novel RSK2 mutations in females with Coffin-Lowry syndrome.
Jurkiewicz D; Jezela-Stanek A; Ciara E; Piekutowska-Abramczuk D; Kugaudo M; Gajdulewicz M; Chrzanowska K; Popowska E; Krajewska-Walasek M
Eur J Med Genet; 2010; 53(5):268-73. PubMed ID: 20637903
[TBL] [Abstract][Full Text] [Related]
29. Recruitment and activation of RSK2 by HIV-1 Tat.
Hetzer C; Bisgrove D; Cohen MS; Pedal A; Kaehlcke K; Speyerer A; Bartscherer K; Taunton J; Ott M
PLoS One; 2007 Jan; 2(1):e151. PubMed ID: 17225856
[TBL] [Abstract][Full Text] [Related]
30. Mutations in the RSK2(RPS6KA3) gene cause Coffin-Lowry syndrome and nonsyndromic X-linked mental retardation.
Field M; Tarpey P; Boyle J; Edkins S; Goodship J; Luo Y; Moon J; Teague J; Stratton MR; Futreal PA; Wooster R; Raymond FL; Turner G
Clin Genet; 2006 Dec; 70(6):509-15. PubMed ID: 17100996
[TBL] [Abstract][Full Text] [Related]
31. A novel RSK2 (RPS6KA3) gene mutation associated with abnormal brain MRI findings in a family with Coffin-Lowry syndrome.
Wang Y; Martinez JE; Wilson GL; He XY; Tuck-Muller CM; Maertens P; Wertelecki W; Chen TJ
Am J Med Genet A; 2006 Jun; 140(12):1274-9. PubMed ID: 16691578
[TBL] [Abstract][Full Text] [Related]
32. The Coffin-Lowry syndrome-associated protein RSK2 regulates neurite outgrowth through phosphorylation of phospholipase D1 (PLD1) and synthesis of phosphatidic acid.
Ammar MR; Humeau Y; Hanauer A; Nieswandt B; Bader MF; Vitale N
J Neurosci; 2013 Dec; 33(50):19470-9. PubMed ID: 24336713
[TBL] [Abstract][Full Text] [Related]
33. Periventricular small cystic lesions in a patient with Coffin-Lowry syndrome who exhibited a novel mutation in the RPS6KA3 gene.
Miyata Y; Saida K; Kumada S; Miyake N; Mashimo H; Nishida Y; Shirai I; Kurihara E; Nakata Y; Matsumoto N
Brain Dev; 2018 Aug; 40(7):566-569. PubMed ID: 29678278
[TBL] [Abstract][Full Text] [Related]
34. The Coffin-Lowry syndrome-associated protein RSK2 is implicated in calcium-regulated exocytosis through the regulation of PLD1.
Zeniou-Meyer M; Liu Y; Béglé A; Olanich ME; Hanauer A; Becherer U; Rettig J; Bader MF; Vitale N
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8434-9. PubMed ID: 18550821
[TBL] [Abstract][Full Text] [Related]
35. Rsk2 Knockout Affects Emotional Behavior in the IntelliCage.
Fischer M; Cabello V; Popp S; Krackow S; Hommers L; Deckert J; Lesch KP; Schmitt-Böhrer AG
Behav Genet; 2017 Jul; 47(4):434-448. PubMed ID: 28585192
[TBL] [Abstract][Full Text] [Related]
36. RSK2 mutation co-segregates with X-linked intellectual disability and attenuated Coffin-Lowry phenotype in a three-generation family.
Maystadt I; Destree A; Benoit V; Aeby A; Lederer D; Moortgat S; Jurkiewicz D; Krajewska-Walasek M; Hanauer A; Thomas GM
Clin Genet; 2014 Jan; 85(1):96-9. PubMed ID: 23495752
[No Abstract] [Full Text] [Related]
37. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.
Mérienne K; Jacquot S; Zeniou M; Pannetier S; Sassone-Corsi P; Hanauer A
Oncogene; 2000 Aug; 19(37):4221-9. PubMed ID: 10980595
[TBL] [Abstract][Full Text] [Related]
38. Unusual splice-site mutations in the RSK2 gene and suggestion of genetic heterogeneity in Coffin-Lowry syndrome.
Zeniou M; Pannetier S; Fryns JP; Hanauer A
Am J Hum Genet; 2002 Jun; 70(6):1421-33. PubMed ID: 11992250
[TBL] [Abstract][Full Text] [Related]
39. Gene symbol: RPS6KA3.
Chen TJ; Wang Y; Martinez JE; Wilson GL; He XY; Tuck-Muller CM; Maertens P; Wertelecki W; Chen TJ
Hum Genet; 2007 Apr; 121(2):288. PubMed ID: 17598200
[No Abstract] [Full Text] [Related]
40. Altered neurodevelopment associated with mutations of RSK2: a morphometric MRI study of Coffin-Lowry syndrome.
Kesler SR; Simensen RJ; Voeller K; Abidi F; Stevenson RE; Schwartz CE; Reiss AL
Neurogenetics; 2007 Apr; 8(2):143-7. PubMed ID: 17318637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
